B-type natruiretic peptide (BNP) in the clinical titration of beta blocker dosage in heart failure patients

被引：0
|
作者：
Mielniczuk, LM [1 ]
Davies, RF [1 ]
da Silva, LB [1 ]
de Bold, AJ [1 ]
Fraser, M [1 ]
Struthers, C [1 ]
Haddad, H [1 ]
机构：
[1] Univ Ottawa, Inst Heart, Ottawa, ON, Canada
来源：
JOURNAL OF CARDIAC FAILURE | 2004年 / 10卷 / 04期
关键词：
D O I：
10.1016/j.cardfail.2004.06.392
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
393
引用
收藏
页码：S123 / S123
页数：1
相关论文
共 50 条
  • [31] B-type natriuretic peptide for congestive heart failure
    Wu, AHB
    JOURNAL OF CLINICAL LIGAND ASSAY, 2002, 25 (02): : 155 - 159
  • [32] Evaluation of the B-Type Natriuretic Peptide (BNP) and Pro-Brain Natriuretic Peptide (NT-pro-BNP) in congestive heart failure (CHF) patients.
    Kampa, IS
    Keffer, P
    CLINICAL CHEMISTRY, 2003, 49 (06) : A32 - A33
  • [33] B-type natriuretic peptide and Doppler echocardiography for identifying CHF patients at risk of acute heart failure decompensation during beta-blockade titration
    Ben Driss, A
    Tabet, JY
    Meurin, P
    Weber, H
    Renaud, N
    Grosdemouge, A
    Bourmayan, C
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 155A - 155A
  • [34] Qualitative and quantitative assessment of B-type natriuretic peptide (BNP) in patients with chronic heart failure using sensitive MSIA technology
    Schellenberger, U.
    Kiernan, U. A.
    Niederkofler, E. E.
    O'Rear, J.
    Pollitt, N. S.
    Protter, A. A.
    Nelson, R. W.
    MOLECULAR & CELLULAR PROTEOMICS, 2006, 5 (10) : S78 - S78
  • [35] Levosimendan benefits critically ill patients with decompensated heart failure assessed with plasma B-type natriuretic peptide (BNP) and LVEF
    AS McLean
    SJ Huang
    B Tang
    M Nalos
    Critical Care, 7 (Suppl 2):
  • [36] Time course of B-Type natriuretic peptide (BNP) and N-terminal ProBNP changes in patients with decompensated heart failure
    Gegenhuber, A
    Mueller, T
    Firlinger, F
    Lenz, K
    Poelz, W
    Haltmayer, M
    CLINICAL CHEMISTRY, 2004, 50 (02) : 454 - 456
  • [37] Clinical implications of normal B-type natriuretic peptide levels in patients with severe chronic heart failure
    Gao, Changzheng
    Lu, Qi
    Guo, Suxia
    Yang, Zhenyu
    Li, Kulin
    Wang, Qiang
    Wang, Ruxing
    ASIAN BIOMEDICINE, 2014, 8 (04) : 493 - 497
  • [38] B-type natriuretic peptide as a marker of the effects of enalapril in patients with heart failure
    Yoshimura, M
    Mizuno, Y
    Nakayama, M
    Sakamoto, T
    Sugiyama, S
    Kawano, H
    Soejima, H
    Hirai, N
    Saito, Y
    Nakao, K
    Yasue, H
    Ogawa, H
    AMERICAN JOURNAL OF MEDICINE, 2002, 112 (09): : 716 - 720
  • [39] Using B-type natriuretic peptide to diagnose heart failure in obese patients
    Daniels, LB
    Clopton, P
    Chiu, A
    McCord, J
    Hollander, JE
    Duc, P
    Omland, T
    Storrow, AB
    Wu, AHB
    Steg, G
    Westheim, A
    Knudsen, CW
    Herrmann, HC
    McCullough, PA
    Maisel, AS
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 141A - 141A
  • [40] B-type natriuretic peptide levels in obese patients with advanced heart failure
    Horwich, TB
    Hamilton, MA
    Fonarow, GC
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (01) : 85 - 90
12345